188Re-anti-CD20 monoclonal antibody

188Re-anti-CD20 for the treatment of non-Hodgkin's lymphoma

Also Known As:

(188)Re-anti-CD20

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Arteaga de Murphy, Consuelo: 1 article (01/2008)
2.	Correa-González, Luis: 1 article (01/2008)
3.	Ferro-Flores, Guillermina: 1 article (01/2008)
4.	Pichardo-Romero, Pablo A: 1 article (01/2008)
5.	Torres-García, Eugenio: 1 article (01/2008)

1.	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/01/2008 - "Our aim was to establish the biokinetics of (188)Re-anti-CD20 in patients and to evaluate its dosimetry as a target-specific radiopharmaceutical for non-Hodgkin's lymphoma (NHL) radioimmunotherapy. "

1.	Radiopharmaceuticals

1.	Radioimmunotherapy